Halogenated anthraquinones in breast cancer therapy:Structural modifications targeting VEGF-related angiogenesis pathwaysOA
Halogenated anthraquinones in breast cancer therapy:Structural modifications targeting VEGF-related angiogenesis pathways
Chenyu Zhou;Murni Nazira Sarian;Xiaohui Tong;Rongchun Han;Theebaa Anasamy;Hamizah Shahirah Hamezah
Institute of Systems Biology(INBIOSIS),Universiti Kebangsaan Malaysia,UKM,Bangi,Selangor,43600,MalaysiaInstitute of Systems Biology(INBIOSIS),Universiti Kebangsaan Malaysia,UKM,Bangi,Selangor,43600,MalaysiaSchool of Life Sciences,Anhui University of Chinese Medicine,Hefei,230012,ChinaSchool of Pharmacy,Anhui University of Chinese Medicine,Hefei,230012,ChinaFaculty of Medicine,Manipal University College Malaysia(MUCM),Jalan Padang Jambu,Bukit Baru,Melaka,75150,MalaysiaInstitute of Systems Biology(INBIOSIS),Universiti Kebangsaan Malaysia,UKM,Bangi,Selangor,43600,Malaysia
Breast cancerAnti-angiogenesisVEGF pathwayStructure-activity relationshipsHalogenated anthraquinones
Breast cancerAnti-angiogenesisVEGF pathwayStructure-activity relationshipsHalogenated anthraquinones
《药物分析学报(英文)》 2026 (6)
1672-1689,18
This work was supported by Universiti Kebangsaan Malaysia under Dana Impak Perdana 2.0 Research Grant to HSH(Grant No.:DIP-2024-021).The Manipal University College Malaysia under MUCM-MRB Joint Seed Grant to TA(Grant No.:MUCM-MRB/002/2024)also supported this work.Figs.1-4 and the graphical ab-stract were created by using BioRender.com under a publication license.
评论